| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| prazosin | alpha-1a adrenergic receptor | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Chronic Obstructive Airway Disease[MeSHID:D029424] Respiratory physiology[MeSHID:D012143] Asthma[MeSHID:D001249] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.54 | approved | antagonist |
| prazosin | alpha-1a adrenergic receptor | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Chronic Obstructive Airway Disease[MeSHID:D029424] Respiratory physiology[MeSHID:D012143] Asthma[MeSHID:D001249] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Congestive heart failure[MeSHID:D006333] Benign Prostatic Hyperplasia[MeSHID:D011470] |
0.54 | approved | antagonist |
| prazosin | alpha-1 adrenergic receptors | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Chronic Obstructive Airway Disease[MeSHID:D029424] Respiratory physiology[MeSHID:D012143] Asthma[MeSHID:D001249] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Congestive heart failure[MeSHID:D006333] Benign Prostatic Hyperplasia[MeSHID:D011470] |
0.54 | approved | unknown |
| prazosin | alpha-1 adrenergic receptors | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Chronic Obstructive Airway Disease[MeSHID:D029424] Respiratory physiology[MeSHID:D012143] Asthma[MeSHID:D001249] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Congestive heart failure[MeSHID:D006333] Benign Prostatic Hyperplasia[MeSHID:D011470] |
0.54 | approved | antagonist |
| prazosin | alpha-1 adrenergic receptors | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Chronic Obstructive Airway Disease[MeSHID:D029424] Respiratory physiology[MeSHID:D012143] Asthma[MeSHID:D001249] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.54 | approved | unknown |
| prazosin | alpha-1 adrenergic receptors | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Chronic Obstructive Airway Disease[MeSHID:D029424] Respiratory physiology[MeSHID:D012143] Asthma[MeSHID:D001249] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.54 | approved | antagonist |
| prazosin | alpha-1 adrenergic receptors | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Chronic Obstructive Airway Disease[MeSHID:D029424] Respiratory physiology[MeSHID:D012143] Asthma[MeSHID:D001249] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.68 | approved | unknown |
| prazosin | alpha-1 adrenergic receptors | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Chronic Obstructive Airway Disease[MeSHID:D029424] Respiratory physiology[MeSHID:D012143] Asthma[MeSHID:D001249] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Congestive heart failure[MeSHID:D006333] Benign Prostatic Hyperplasia[MeSHID:D011470] |
0.68 | approved | antagonist |
| prazosin | alpha-1b adrenergic receptor | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Chronic Obstructive Airway Disease[MeSHID:D029424] Respiratory physiology[MeSHID:D012143] Asthma[MeSHID:D001249] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Congestive heart failure[MeSHID:D006333] Benign Prostatic Hyperplasia[MeSHID:D011470] |
0.68 | approved | antagonist |
| prazosin | alpha-1b adrenergic receptor | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Chronic Obstructive Airway Disease[MeSHID:D029424] Respiratory physiology[MeSHID:D012143] Asthma[MeSHID:D001249] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.68 | approved | antagonist |
| prazosin | alpha-1 adrenergic receptors | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Chronic Obstructive Airway Disease[MeSHID:D029424] Respiratory physiology[MeSHID:D012143] Asthma[MeSHID:D001249] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.68 | approved | antagonist |
| prazosin | alpha-1 adrenergic receptors | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Chronic Obstructive Airway Disease[MeSHID:D029424] Respiratory physiology[MeSHID:D012143] Asthma[MeSHID:D001249] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Congestive heart failure[MeSHID:D006333] Benign Prostatic Hyperplasia[MeSHID:D011470] |
0.68 | approved | unknown |
| prazosin | alpha-1d adrenergic receptor | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Chronic Obstructive Airway Disease[MeSHID:D029424] Respiratory physiology[MeSHID:D012143] Asthma[MeSHID:D001249] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Congestive heart failure[MeSHID:D006333] Benign Prostatic Hyperplasia[MeSHID:D011470] |
0.68 | approved | antagonist |
| prazosin | alpha-1 adrenergic receptors | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Chronic Obstructive Airway Disease[MeSHID:D029424] Respiratory physiology[MeSHID:D012143] Asthma[MeSHID:D001249] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.68 | approved | antagonist |
| prazosin | alpha-1 adrenergic receptors | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Chronic Obstructive Airway Disease[MeSHID:D029424] Respiratory physiology[MeSHID:D012143] Asthma[MeSHID:D001249] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Congestive heart failure[MeSHID:D006333] Benign Prostatic Hyperplasia[MeSHID:D011470] |
0.68 | approved | antagonist |
| prazosin | alpha-1d adrenergic receptor | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Chronic Obstructive Airway Disease[MeSHID:D029424] Respiratory physiology[MeSHID:D012143] Asthma[MeSHID:D001249] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.68 | approved | antagonist |
| prazosin | alpha-1 adrenergic receptors | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Chronic Obstructive Airway Disease[MeSHID:D029424] Respiratory physiology[MeSHID:D012143] Asthma[MeSHID:D001249] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.68 | approved | unknown |
| prazosin | alpha-1 adrenergic receptors | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Chronic Obstructive Airway Disease[MeSHID:D029424] Respiratory physiology[MeSHID:D012143] Asthma[MeSHID:D001249] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Congestive heart failure[MeSHID:D006333] Benign Prostatic Hyperplasia[MeSHID:D011470] |
0.68 | approved | unknown |
| prazosin | alpha-2a adrenergic receptor | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Chronic Obstructive Airway Disease[MeSHID:D029424] Respiratory physiology[MeSHID:D012143] Asthma[MeSHID:D001249] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Congestive heart failure[MeSHID:D006333] Benign Prostatic Hyperplasia[MeSHID:D011470] |
0.25 | approved | binder,antagonist |
| prazosin | alpha-2a adrenergic receptor | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Chronic Obstructive Airway Disease[MeSHID:D029424] Respiratory physiology[MeSHID:D012143] Asthma[MeSHID:D001249] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.25 | approved | binder,antagonist |
| prazosin | alpha-2b adrenergic receptor | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Chronic Obstructive Airway Disease[MeSHID:D029424] Respiratory physiology[MeSHID:D012143] Asthma[MeSHID:D001249] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Congestive heart failure[MeSHID:D006333] Benign Prostatic Hyperplasia[MeSHID:D011470] |
0.45 | approved | binder,antagonist |
| prazosin | alpha-2b adrenergic receptor | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Chronic Obstructive Airway Disease[MeSHID:D029424] Respiratory physiology[MeSHID:D012143] Asthma[MeSHID:D001249] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.45 | approved | binder,antagonist |
| prazosin | potassium voltage-gated channel subfamily h member 2 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Chronic Obstructive Airway Disease[MeSHID:D029424] Respiratory physiology[MeSHID:D012143] Asthma[MeSHID:D001249] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| prazosin | potassium voltage-gated channel subfamily h member 2 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Chronic Obstructive Airway Disease[MeSHID:D029424] Respiratory physiology[MeSHID:D012143] Asthma[MeSHID:D001249] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Congestive heart failure[MeSHID:D006333] Benign Prostatic Hyperplasia[MeSHID:D011470] |
NA | approved | inhibitor |
| click here to return to the previous page | ||||||||